Beigene logo

BGNE - Beigene Share Price

$170.36 2.5  1.5%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £10.12bn
Enterprise Value £9.39bn
Revenue £328.8m
Position in Universe 658th / 6416
Bullish
Bearish
Unlock BGNE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BGNE Revenue Unlock BGNE Revenue

Net Income

BGNE Net Income Unlock BGNE Revenue

Normalised EPS

BGNE Normalised EPS Unlock BGNE Revenue

PE Ratio Range

BGNE PE Ratio Range Unlock BGNE Revenue

Dividend Yield Range

BGNE Dividend Yield Range Unlock BGNE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BGNE EPS Forecasts Unlock BGNE Revenue
Profile Summary

BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and Pamiparib (BGB-290).

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated October 28, 2010
Public Since February 3, 2016
No. of Shareholders: 166
No. of Employees: 3,000
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market (Dual Listing)
Shares in Issue 77,054,097
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BGNE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BGNE
Upcoming Events for BGNE
Tuesday 25th February, 2020 Estimate
Q4 2019 Beigene Ltd Earnings Release
Thursday 7th May, 2020 Estimate
Q1 2020 Beigene Ltd Earnings Release
Thursday 4th June, 2020 Estimate
BeiGene Ltd Annual Shareholders Meeting
Similar to BGNE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.